Compound information
- Natural Products
- ZC924483
- Molecular Formula
- C16H24N2O4S
- Molecular Weight
- 340.145678248 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(p-tolylsulfonyl)piperazine-1-carboxylate
- InChI
- InChI=1S/C16H24N2O4S/c1-13-5-7-14(8-6-13)23(20,21)18-11-9-17(10-12-18)15(19)22-16(2,3)4/h5-8H,9-12H2,1-4H3
- InChI Key
- RMMKVNCWKMPISN-UHFFFAOYSA-N
- SMILES
- Cc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1
- Source
- ZINC000017071256
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 2.759 |
LogS | -3.671 | LogD | 3.529 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.075 | Pgp substrate | 0.016 |
HIA | 0.972 | F20 % | 0.992 |
F30 % | 0.967 | Caco-2 | -4.394 |
MDCK | -4.805 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.711 | PPB | 91.591 |
VD | 2.034 | Fu | 0.806 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.03 | CYP1A2 substrate | 0.492 |
CYP2A6 substrate | 0.636 | CYP2B6 substrate | 0.659 |
CYP2C19 inhibitor | 0.901 | CYP2C19 substrate | 0.838 |
CYP2C8 substrate | 0.667 | CYP2C9 inhibitor | 0.642 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.051 |
CYP2D6 substrate | 0.899 | CYP2E1 substrate | 0.903 |
CYP3A4 inhibitor | 0.174 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.385 | CL | 7.174 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.985 | Hepatotoxicity | 0.95 |
Mutagenicity | 0.223 | Rat Oral Acute Toxicity | 0.14 |
FDAMDD | 0.036 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.889 | Eye Corrosion | 0.01 |
Eye Irritation | 0.089 | Respiratory Toxicity | 0.097 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.732 | IGC50 | 3.237 |
LC50FM | 2.766 | LC50DM | 2.456 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.226 | NR-AR-LBD | 0.273 |
NR-AhR | 0.026 | NR-Aromatase | 0.375 |
NR-ER | 0.242 | NR-ER-LBD | 0.369 |
NR-PPAR-gamma | 0.125 | SR-ARE | 0.759 |
SR-ATAD5 | 0.375 | SR-HSE | 0.077 |
SR-MMP | 0.017 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.